The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2018 | MDS news from ASH 2018
Alan List
• 15 Jan 2019
In this video, Alan List, MD, of Moffitt Cancer Center, Tampa, FL, delivers highlights on myelodysplastic syndrome (MDS) therapies from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA. Dr List discusses clinical trials, novel treatments, and progressions which are pushing our understanding of the disease, bringing light to new pathways that can be targeted.
